Ricard Ferrer - Concepedia

Author

Ricard Ferrer

Also Known As

Adrián Ceccato, Angel Estella, Antonin Falck, Antonio Pesenti, Antonio Torres Marti, Arturo Muriel-Bombín, CIBERESUCICOVID Project (COV20/00110, ISCIII), David Suarez, F. Álvarez-Lerma, Ferrer, Ricard

554

Publications

36.5K

Citations

H-Index

125

Concepts

All Affiliations

Vall d'Hebron Institut de Recerca Vall d'Hebron Hospital Universitari Universitat Autònoma de Barcelona Centro de Investigación Biomédica en Red de Enfermedades Respiratorias Universitat de Barcelona

About

Ricard Ferrer is an author at Vall d'Hebron Institut de Recerca specializing in medicine, patient safety, and sepsis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	56	15K
2	Public Health	9	9	692
3	Health Sciences	6	6	923
4	Engineering	2	2	203
5	Nursing	1	1	44

Ricard Ferrer

149

Publications

29.3K

Citations

H-Index

Page 1

	Year	Citations
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Andrew Rhodes, Laura Evans, Waleed Alhazzani, Intensive Care Medicine Trauma ResuscitationCritical Care ManagementAcute CarePatient SafetyInternational Health	2017	6.5K
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Laura Evans, Andrew Rhodes, Waleed Alhazzani, Intensive Care Medicine Critical Care ManagementAcute CarePatient SafetyInternational HealthSepsis	2021	4.5K
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Andrew Rhodes, Laura Evans, Waleed Alhazzani, Critical Care Medicine	2017	3.7K
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021 Laura Evans, Andrew Rhodes, Waleed Alhazzani, Critical Care Medicine	2021	2.5K
Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour Ricard Ferrer, Ignacio Martín‐Loeches, Gary Phillips, Critical Care Medicine	2014	1.4K
Improvement in Process of Care and Outcome After a Multicenter Severe Sepsis Educational Program in Spain Ricard Ferrer JAMA	2008	735
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial Matteo Bassetti, Roger Echols, Yuko Matsunaga, The Lancet Infectious Diseases Antimicrobial SusceptibilityHealth SciencesCarbapenem-resistant Gram-negative BacteriaKlebsiella PneumoniaeAntimicrobial Therapy	2020	732
Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021 Laura Evans, Andrew Rhodes, Waleed Alhazzani, Critical Care Medicine	2021	460
Effectiveness of Treatments for Severe Sepsis Ricard Ferrer, Antonio Artigas, David L. Suarez, American Journal of Respiratory and Critical Care Medicine	2009	410
The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study) Andrew Rhodes, Gary Phillips, Richard Beale, Intensive Care Medicine Impress StudySepsis Campaign BundlesAcute CareInternational HealthSepsis	2015	394

Page 1